15 April 2021 | 14:00 CET
Press release: Global leaders rally to accelerate access to COVID-19 vaccines for lower-income countries
On 15 April, Gavi and the United States government brought together world leaders, the private sector, civil society and key technical partners to galvanise resources and commitment to the Gavi COVAX Advance Market Commitment (Gavi COVAX AMC).
The One World Protected event launched the Investment Opportunity for the Gavi COVAX AMC, outlining the urgent need for its continued support and paving the way for a funding Summit in June.
|
|
José Manuel Barroso |
|
|
|
Antony Blinken |
|
|
|
Gloria Steele |
|
>143
million
pandemic-induced global new poor in 2021.
US$ 9
trillion
potential loss to the global economy if COVID-19 vaccines aren’t globally distributed.
1.8
billion
doses of COVID-19 vaccine could be reserved through the Gavi COVAX AMC in 2021.
92
lower-income economies
stand to benefit from COVID-19 vaccines provided through the Gavi COVAX AMC.
≥ US$ 2
billion
is required by June 2021 to fully fund the Gavi COVAX AMC.

The Gavi COVAX Advance Market Commitment (AMC) is an innovative financial mechanism that ensures the world’s poorest countries will get access to COVID-19 vaccines, regardless of their ability to pay.
In addition to committing US$ 4 billion over 2021 and 2022 to support Gavi’s COVID-19 related work, the U.S. is a long-standing supporter of Gavi. It was one of the Alliance’s original six donors and has contributed more than US$ 2.7 billion to our core work since 2000.
U.S. global health assistance has emphasised ending preventable child deaths through high-impact, low-cost interventions, and provision of vaccines and immunisations through Gavi is an important component of these efforts. Moreover, the United States continues to be a key partner to Gavi by coordinating programmatic objectives to ensure greater efficiency and impact on the ground.